Molecular farming using transgenic rice endosperm

Trends Biotechnol. 2022 Oct;40(10):1248-1260. doi: 10.1016/j.tibtech.2022.04.002. Epub 2022 May 10.

Abstract

Plant expression platforms are low-cost, scalable, safe, and environmentally friendly systems for the production of recombinant proteins and bioactive metabolites. Rice (Oryza sativa L.) endosperm is an ideal bioreactor for the production and storage of high-value active substances, including pharmaceutical proteins, oral vaccines, vitamins, and nutraceuticals such as flavonoids and carotenoids. Here, we explore the use of molecular farming from producing medicines to developing functional food crops (biofortification). We review recent progress in producing pharmaceutical proteins and bioactive substances in rice endosperm and compare this platform with other plant expression systems. We describe how rice endosperm could be modified to design metabolic pathways and express and store stable products and discuss the factors restricting the commercialization of transgenic rice products and future prospects.

Keywords: bioactive metabolites; bioreactor; molecular farming; recombinant proteins; rice (Oryza sativa L.) endosperm; synthetic biology.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotenoids
  • Endosperm* / genetics
  • Endosperm* / metabolism
  • Flavonoids
  • Gene Expression Regulation, Plant
  • Molecular Farming
  • Oryza* / genetics
  • Oryza* / metabolism
  • Pharmaceutical Preparations / metabolism
  • Plant Proteins
  • Plants, Genetically Modified / genetics
  • Plants, Genetically Modified / metabolism
  • Recombinant Proteins / metabolism
  • Vitamins / metabolism

Substances

  • Flavonoids
  • Pharmaceutical Preparations
  • Plant Proteins
  • Recombinant Proteins
  • Vitamins
  • Carotenoids